SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 820.58 |
| Enterprise Value ($M) | 349.20 |
| Book Value ($M) | 486.93 |
| Book Value / Share | 9.05 |
| Price / Book | 1.69 |
| NCAV ($M) | 425.23 |
| NCAV / Share | 7.90 |
| Price / NCAV | 1.93 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.25 |
| Return on Assets (ROA) | -0.18 |
| Return on Equity (ROE) | -0.22 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 10.01 |
| Current Ratio | 10.01 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 485.41 |
| Assets | 547.11 |
| Liabilities | 60.18 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 135.16 |
| Operating Income | -154.56 |
| Net Income | -122.31 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Scully William P | |||
| 13G/A | Fennell Todd W. | |||
| 13G/A | Wellington Management Group Llp | |||
| 13D/A | EcoR1 Capital, LLC | |||
| 13G/A | Price T Rowe Associates Inc /md/ | 7.10 | -9.91 | |
| 13G/A | State Street Corp | 3.10 | -39.28 | |
| 13G/A | Avidity Partners Management LP | 0.00 | -100.00 | |
| 13G/A | Fmr Llc | 15.00 | 52.90 | |
| 13G/A | BlackRock, Inc. | 7.00 | 8.19 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 159,154 | 649,681 | 24.50 | |
| 93,743 | 305,669 | 30.67 | |
| 110,830 | 414,447 | 26.74 | |
| 61,561 | 227,619 | 27.05 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PMVP – PMV Pharmaceuticals, Inc. | PRAX – Praxis Precision Medicines, Inc. |
| PRLD – Prelude Therapeutics Incorporated | PTCT – PTC Therapeutics, Inc. |
| PYXS – Pyxis Oncology, Inc. |
Financial data and stock pages provided by
Fintel.io